These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21106989)

  • 1. CP-690,550, a therapeutic agent, inhibits cytokine-mediated Jak3 activation and proliferation of T cells from patients with ATL and HAM/TSP.
    Ju W; Zhang M; Jiang JK; Thomas CJ; Oh U; Bryant BR; Chen J; Sato N; Tagaya Y; Morris JC; Janik JE; Jacobson S; Waldmann TA
    Blood; 2011 Feb; 117(6):1938-46. PubMed ID: 21106989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine induction in HTLV-I associated myelopathy and adult T-cell leukemia: alternate molecular mechanisms underlying retroviral pathogenesis.
    Tendler CL; Greenberg SJ; Burton JD; Danielpour D; Kim SJ; Blattner WA; Manns A; Waldmann TA
    J Cell Biochem; 1991 Aug; 46(4):302-11. PubMed ID: 1757474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective targeting of JAK/STAT signaling is potentiated by Bcl-xL blockade in IL-2-dependent adult T-cell leukemia.
    Zhang M; Mathews Griner LA; Ju W; Duveau DY; Guha R; Petrus MN; Wen B; Maeda M; Shinn P; Ferrer M; Conlon KD; Bamford RN; O'Shea JJ; Thomas CJ; Waldmann TA
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12480-5. PubMed ID: 26396258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Saito M; Matsuzaki T; Satou Y; Yasunaga J; Saito K; Arimura K; Matsuoka M; Ohara Y
    Retrovirology; 2009 Feb; 6():19. PubMed ID: 19228429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of IL-15 in the pathogenesis of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: implications for therapy with a monoclonal antibody directed to the IL-2/15R beta receptor.
    Azimi N; Jacobson S; Leist T; Waldmann TA
    J Immunol; 1999 Oct; 163(7):4064-72. PubMed ID: 10491011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
    J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis.
    Nozuma S; Kubota R; Jacobson S
    J Neurovirol; 2020 Oct; 26(5):652-663. PubMed ID: 32705480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-10-mediated signals act as a switch for lymphoproliferation in Human T-cell leukemia virus type-1 infection by activating the STAT3 and IRF4 pathways.
    Sawada L; Nagano Y; Hasegawa A; Kanai H; Nogami K; Ito S; Sato T; Yamano Y; Tanaka Y; Masuda T; Kannagi M
    PLoS Pathog; 2017 Sep; 13(9):e1006597. PubMed ID: 28910419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A refractory human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patient with lymphoma-type adult T-cell leukemia/lymphoma: A case report and review of the literature.
    Tamaki K; Mera H; Takeshita S; Fujioka S; Goto M; Matsumoto T; Yamano Y; Takamatsu Y; Tsuboi Y
    Medicine (Baltimore); 2021 Oct; 100(40):e27450. PubMed ID: 34622865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentosan Polysulfate Demonstrates Anti-human T-Cell Leukemia Virus Type 1 Activities
    Ma G; Yasunaga JI; Ohshima K; Matsumoto T; Matsuoka M
    J Virol; 2019 Aug; 93(16):. PubMed ID: 31167921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).
    Baratella M; Forlani G; Raval GU; Tedeschi A; Gout O; Gessain A; Tosi G; Accolla RS
    PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005285. PubMed ID: 28095504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
    Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
    Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis, and adult T-cell leukemia/lymphoma.
    Giusti RM; Maloney EM; Hanchard B; Morgan OS; Steinberg SM; Wachter H; Williams E; Cranston B; Fuchs D; Manns A
    Cancer Epidemiol Biomarkers Prev; 1996 Sep; 5(9):699-704. PubMed ID: 8877061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: pathogenic implications and a rationale for immunotherapy.
    Tendler CL; Greenberg SJ; Blattner WA; Manns A; Murphy E; Fleisher T; Hanchard B; Morgan O; Burton JD; Nelson DL
    Proc Natl Acad Sci U S A; 1990 Jul; 87(13):5218-22. PubMed ID: 2367534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease.
    Oh U; McCormick MJ; Datta D; Turner RV; Bobb K; Monie DD; Sliskovic DR; Tanaka Y; Zhang J; Meshulam J; Jacobson S
    Blood; 2011 Mar; 117(12):3363-9. PubMed ID: 21212284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and immunovirology of human T-cell leukemia/lymphoma virus type I-associated adult T-cell leukemia and chronic myelopathies as seen in France.
    Gessain A; Gout O; Saal F; Daniel MT; Rio B; Flandrin G; Sigaux F; Lyon-Caen O; Periès J; de-Thé G
    Cancer Res; 1990 Sep; 50(17 Suppl):5692S-5696S. PubMed ID: 2201441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of JAK-STAT Signaling Suppresses Pathogenic Immune Responses in Medium and Large Vessel Vasculitis.
    Zhang H; Watanabe R; Berry GJ; Tian L; Goronzy JJ; Weyand CM
    Circulation; 2018 May; 137(18):1934-1948. PubMed ID: 29254929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
    Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
    Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
    Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
    J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult T cell leukemia following HTLV-I-associated myelopathy/tropical spastic paraparesis: case reports and implication to the natural course of ATL.
    Tamiya S; Matsuoka M; Takemoto S; Shimizu K; Yamaguchi K; Mita S; Uchino M; Ando M; Miyaguni T; Kuniyoshi K
    Leukemia; 1995 Oct; 9(10):1768-70. PubMed ID: 7564523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.